Duncan McHale, M.B.B.S., Ph.D., has served as Chief Medical Officer since 2018. Prior to joining Evelo, Duncan was Director and Chief Executive Officer at Weatherden, Ltd., a clinical development consultancy firm. From 2011-2017, Duncan was the Head of Global Exploratory Development at UCB S.A, and prior to that as Head of Translational Sciences at AstraZeneca. Duncan received his M.B.B.S. from Newcastle University and his Ph.D. from the University of Leeds.
Duncan McHale, M.B.B.S., Ph.D.
Chief Medical Officer